|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Agammaglobulinemia | |||||
| Common Variable Immunodeficiency | |||||
| Immunologic Deficiency Syndrome | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Immunologic Deficiency Syndromes | |||||
| Syndrome | |||||
| 3 | More general conditions related to this trial | ||||
| Blood Protein Disorders | |||||
| Disease | |||||
| Hematologic Diseases | |||||
| Immune System Diseases | |||||
| Lymphatic Diseases | |||||
| Lymphoproliferative Disorders | |||||
| Pathologic Processes | |||||
| 4 | Sponsors listed in this trial | ||||
| National Institute of Allergy and Infectious Diseases (NIAID) | |||||